Detailed Narrative
Q1 FY26 Performance Overview and Growth Drivers
Bodal Chemicals reported a consolidated revenue of ₹458 crores for Q1 FY26, marking an 8% year-on-year growth. Absolute EBITDA increased by 40% year-on-year to ₹52 crores, resulting in a consolidated EBITDA margin of 11.3%. This growth was primarily attributed to better realization. However, increased overheads from the capitalization of the Saykha's Benzene downstream project partially offset profitability, as the project did not significantly contribute to the top line during the quarter.
Segmental Performance Analysis
The Dye Intermediates division recorded ₹150 crores in revenue, a 4% year-on-year degrowth, mainly due to lower raw material prices and the non-operation of the beta naphthol plant. Dyestuff revenue also saw a 10% degrowth to ₹122 crores. In contrast, Basic Chemicals revenue grew by 15% year-on-year to ₹45 crores, and Chlor Alkali revenue increased by 8% year-on-year to ₹84 crores. The company aims to improve Chlor Alkali capacity utilization to 90-95% in the coming quarters.
Benzene Downstream Project Update and Outlook
The Saykha's Benzene downstream products unit has commenced normal production, contributing ₹13 crores to the top line in Q1 FY26. Current utilization for PNCB and ONCB is about 20% of the 3,000 metric tons per annum capacity. Management targets to increase this utilization to 70% by Q3 FY26 and 80% by Q4 FY26. The company conservatively projects ₹100 crores in revenue from the benzene business for FY26, with a potential to reach ₹300 crores in FY27 at full capacity.
Strategic Land Sale at Rajpura Unit
Bodal Chemicals is in the process of selling approximately 8 acres of surplus land at its Rajpura chlor-alkali unit for ₹5 crores. This is viewed as a strategic business deal rather than a mere real estate transaction, aimed at securing a pipeline buyer for chlorine, which is a bottleneck product. The company retains over 70 acres of surplus land from its total 125 acres for future expansions, ensuring sufficient space for growth without needing to acquire more land.
Capital Allocation and Debt Management
The company's current term debt stands at ₹507 crores, with working capital at ₹350 crores. Management plans a scheduled repayment of ₹120 crores in term debt and aims to reduce overall debt by ₹150-175 crores by the end of the current fiscal year through asset sales. The cost of debt is between 8.5% and 9%. The long-term target for net debt to EBITDA is approximately 2.5, indicating a focus on deleveraging.
Margin Outlook and Industry Dynamics
Management noted that while historical EBITDA margins were in the 18-20% range during a different industry era (2014-2019), the current global environment (post-2022 Ukraine-Russia war) has led to cyclical and pressured margins. The company's current blended EBITDA margin is 10-11%, with a target to improve it by a couple of percentage points to 12-13% going forward⏳. The TCCA segment is expected to see improved pricing (up by ₹50-60) and a 'sizable share' of the Indian market within 1-2 months due to the Anti-Dumping Duty.